About
Specialty Pharmaceuticals
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
5
As Collaborator
0
Total Enrollment
444
By Phase
PHASE2: 1PHASE1: 3PHASE2/PHASE3: 1
By Status
COMPLETED: 5
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
Today
Hover over trial bars to see details
Recent Trials
NCT03578783Lead Sponsor
PSD502 in Subjects With Premature Ejaculation
PHASE2Completed
121 participants
Started: Dec 26, 2018 · Completed: Dec 1, 2021
NCT01184105Lead Sponsor
A Safety and Tolerability of PSD502 (a Topical Anesthetic) in the Treatment of Premature Ejaculation
PHASE1Completed
30 participants
Started: Sep 30, 2010 · Completed: Nov 30, 2010
NCT01183208Lead Sponsor
A Safety and Tolerability Study of Administration of PSD502
PHASE1Completed
21 participants
Started: Dec 31, 2009 · Completed: Feb 28, 2010
NCT00556478Lead Sponsor
Efficacy, Safety and Tolerability of PSD502 (a Topical Anesthetic) in the Treatment Premature Ejaculation
PHASE2/PHASE3Completed
256 participants
Started: Oct 31, 2007 · Completed: Oct 31, 2009
NCT00483990Lead Sponsor
Phase I Study of PSD502 (Lidocaine Prilocaine Spray) Applied to the Glans Penis up to Three Times a Day for 21 Days in Healthy Male Volunteers
PHASE1Completed
16 participants
Started: Mar 31, 2007 · Completed: Jun 30, 2007
Funding History (1)
D
Sep 23, 2014
Locations (1)
Headquarters
Chalgrove, UK
Map
Loading map...